Dr. Suchitra Kumari

Dr. Suchitra Kumari

Addl. Prof.
Biochemistry

biochem_suchitra@aiimsbhubaneswar.edu.in

Biosketch

48

PUBLICATIONS

0

CITATIONS

0

H INDEX

PERSONAL INFORMATION

Dr. Suchitra Kumari

Addl. Prof.

Biochemistry

Degree / Diploma Year of Passing Subject Name of the University/ Institution
M.B.B.S 2000 Medicine, Surgery, Obs & Gyn MKCG Medical College, Berhampur University
MD(Biochemistry) 2006 Biochemistry SCB Medical College, Utkal University
  • Extracellular matrix in Cancer Genetics and Machine Learning approach in clinical diagnosis.

  • Fellow of IMA academy of Medical Specialties
  • Fellow of International Medical Sciences Academy
  • Member of National Academy of Medical Sciences (India)
  • Central executive committee member/co chairman of Scientific committee ACCLMP
  • Secretary (General) Odisha State chapter ACCLMP
  • Life Member of Association of Medical Biochemists of India
  • Life Member of Association of Clinical Biochemists of India
  • Elected Editorial Board member of Asia Pacific Journal of Cancer
  • Elected Editorial Board member of Journal of Applied biochemistry and laboratory Medicine (JABLM)
  • Served as Faculty in state Medical college and National Institute of repute for more than 18 years. Mentored many MD Biochemistry Post graduates as thesis Chief-guide, MBBS students for ICMR short term studentship. She holds the position of MD Biochemistry Thesis adjudicator of West Bengal University of Health Sciences and Kalinga Institute of Medical Sciences, Bhubaneswar. She had also contributed to question bank of National board of Education.She had served as Member Secretary of Internal Complaint Committee and faculty in-charge of the Central Pharmacy of AIIMS, Bhubaneswar. She holds a position as member of MBBS mentoring Committee and Annual Report Committee AIIMS Bhubaneswar.

     

  • Panda, Chhabi Rani ; Mangaraj, Manaswini; Panda, Sandip Kumar; Kumari S; Nayak, Saurav; Saharia, Gautom Kumar. Unravelling interplay of serum MMP-7 and TGF- β in diabetic nephropathy – A study from a tertiary centre in eastern India. Journal of Family Medicine and Primary Care 14(3):p 997-1002, March 2025. | DOI: 10.4103/jfmpc.jfmpc_1158_24
  • Shrivastava A, Kumari S, Mohapatra S.The Diagnostic Performance of Serum Glycosylated Ferritin in Patients Undergoing Regular Blood Transfusion: An Indicator of Iron Overload to Initiate Iron Chelation Therapy. Cureus 2024; 16(8): e66695. DOI 10.7759/cureus.66695
  • Mohapatra S, Das P K , Mahapatra A, Kumari S, Panigrahi A. A Prospective Observational Study of the Prognostic Role of Procalcitonin Compared with High Sensitivity C Reactive Protein in Patients≥15Years of Age with Acute Lymphoblastic Leukemia/ Lymphoma with Febrile Neutropenia. Indian Journal of Hematology and Blood 2024  https://doi.org/10.1007/s12288-024-01832-9
  • Tahseen, A., Kumari, S., Mangaraj, M. Tissue Inhibitor of Metalloproteinase 2 (TIMP 2) Promotor 418 G > C Polymorphism in Non-alcoholic Fatty Liver Disease (NAFLD) Patients of Eastern States of India. Ind J Clin Biochem (2024). https://doi.org/10.1007/s12291-024-01287-9
  • Kumari S, Tripathy S, Nayak S, Rajasimman AS. Machine learning-aided algorithm design for prediction of severity from clinical, demographic, biochemical and immunological parameters: Our COVID-19 experience from the pandemic. J Family Med Prim Care. 2024 May;13(5):1937-1943. doi: 10.4103/jfmpc.jfmpc_1752_23. Epub 2024 May 24. PMID: 38948617; PMCID: PMC11213376.
  • P P A, Kumari S, Dasmajumdar S, Mangaraj M. Matrix Metalloproteinase-7 Promoter Site Single Nucleotide Polymorphism (-181A>G) in Epithelial Ovarian Cancer in the Eastern Indian Population. Cureus. 2024 Mar 18;16(3):e56417. doi: 10.7759/cureus.56417. PMID: 38638796; PMCID: PMC11024387.
  • Kumari, S., Nayak, S. & Mangaraj, M. A New Machine Learning Approach for Actual Calcium Measurement. Ind J Clin Biochem(2024). https://doi.org/10.1007/s12291-024-01182-3
  • Jasti P, Kumari S, Singh S, Anudeep PP. Serum versican as a potential biomarker in patients with uterine fibroids: A study from Eastern India. J Family Med Prim Care. 2023 Aug;12(8):1704-1709. doi: 10.4103/jfmpc.jfmpc_320_23. Epub 2023 Aug 29. PMID: 37767449; PMCID: PMC10521836.
  • Panda CR, Kumari S, Mangaraj M, Nayak S. The Evaluation of the Quality Performance of Biochemical Analytes in Clinical Biochemistry Laboratory Using Six Sigma Matrices. Cureus. 2023 Dec 31;15(12):e51386. doi: 10.7759/cureus.51386. PMID: 38292960; PMCID: PMC10826247.
  • Gayathri Devi, D., Mangaraj, M., Panda, Kumari S .Exploring the Role of Serum Lysyl Oxidase (LOX) Levels and LOX Gene Polymorphism (G473A) in Diabetic Nephropathy. Ind J Clin Biochem (2024). https://doi.org/10.1007/s12291-024-01189-w
  • Somanath P, Bakialaxmi V,Chinmayee P,Susama P, Kumari S.Perforin in Systemic Leupus Erythematosus and associated Macrophage Activation Syndrome. Chapter-2; Advances in health and disease; Editor: Lowell T, Duncan. Nova Science Publishers, Inc.Vol-80; ISBN: 979-8-89113-587-1;19-41.
  • Panda CR, Anudeep PP, Saharia GK, Kumari S, Mangaraj M. Matrix metalloproteinase-7(MMP-7) as a surrogate marker of extracellular matrix remodelling- a comprehensive literature review. J Int Med Sci Acad 2023;36(3): 299-304.
  • Kumari S, Nayak S, Tripathy S, Bhuniya S, Mangaraj M, Ramadass B, Sahu S, Bandyopadhyay D, Dash P, Saharia GK. Analysis of Biochemical and Inflammatory Markers for Predicting COVID-19 Severity: Insights From a Tertiary Healthcare Institution of Eastern India. Cureus. 2023 Jan 17;15(1):e33893. doi: 10.7759/cureus.33893. PMID: 36819455; PMCID: PMC9934847.
  • Kumari S, Patro ARK, Mishra B, Jena SK, Singh S. Serum Lysyl Oxidase Levels and Lysyl Oxidase Gene Polymorphism in Ovarian Cancer Patients of Eastern Indian Population. Diagnostics (Basel). 2021 Dec 28;12(1):53. doi: 10.3390/diagnostics12010053. PMID: 35054220; PMCID: PMC8774920.
  • Kumari S, Parida S P ,Sahu D P, Jena P .Physical, mental, spiritual and social wellbeing of urban population during the COVID19 lockdown phases: a cross-sectional study. Indian Journal of Community Health 2022; 34(2): 213-219.
  • P P A, Kumari S, Rajasimman AS, Nayak S, Priyadarsini P. Machine learning predictive models of LDL-C in the population of eastern India and its comparison with directly measured and calculated LDL-C. Annals of Clinical Biochemistry. 2022;59(1):76-86. doi:1177/00045632211046805
  • Kumari S, Bahinipati J, Pradhan T, Sahoo DP. Comparison of test performance of Biochemical parameters in Manual method and fully automatic analyser method. J Family Med Prim Care 2020; 25;9(8):3994-4000. doi: 10.4103/jfmpc.jfmpc_94_20. PMID: 33110800; PMCID: PMC7586617,
  • Kumari S, Swetha P, Krishnan R S, Nayak S, Singh S. The Association Between Ferritin and Vitamin D Levels in Premenopausal Fibroid Uterus Cases With Anemia. Cureus. 2021 Feb 17;13(2):e13392. doi: 10.7759/cureus.13392. PMID: 33758693; PMCID: PMC7977030.
  • Raghuwanshi B, Kumari S, Sahoo DP. Clinical and Metabolic Complications in patients with thalassemia undergoing transfusion therapy. J Family Med Prim Care. 2020 Feb 28;9(2):973-977. doi: 10.4103/jfmpc.jfmpc_845_19. PMID: 32318453; PMCID: PMC7113988.
  • Kumari S , Nandury B C. Diagnostic  importance of thyroid profile and serum cortisol in patients with  Int J Sci Res 2019;8(3):67-69.
  • Kumari S. Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review. Indian J ClinBiochem. 2018 Oct;33(4):382-386. doi: 10.1007/s12291-018-0786-2. Epub 2018 Aug 6. PMID: 30319183; PMCID: PMC6170235.
  • Panda T K, Kumari S. Clinical picture of vernal keratoconjunctivitis in central Odisha. Evid.Based Med.Healthc.2018; 5(36), 2817-2820. DOI: 10.18410/jebmh/2018/000
  • Kumari S, Baji D B, Singh S. Association of vitamin D, Calcium and Phosphate with uterine fibroid in premenopausal women of coastal Odisha.Int J Sci Res 2019; 8(2): 27-29.
  • Panda T K,Kumari S . Effect of medical and surgical management and dry eyes in Eastern Odisha. Int J Basic ClinPharmacol 2018; 7(10): 1857-1862. DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20180001
  • Kumari S. Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review. Indian J ClinBiochem. 2018 Oct;33(4):382-386. doi: 10.1007/s12291-018-0786-2. Epub 2018 Aug 6. PMID: 30319183; PMCID: PMC6170235.
  • Panda T K, Kumari S. Clinical studies on dry eyes in Eastern Odisha. Evid. Based Med. Healthc.2018; 5(36), 2687-2692.DOI: 10.18410/jebmh/2018/000.
  • Kumari S, Dash I, Behera KK. Therapeutic effect of Momordica charantia on blood glucose ,lipid profile and oxidative stress in Type 2 diabetes Mellitus patients .Journal of clinical diagnosis and research 2018;12(9):BC21-BC25 .
  • Kumari S. Prenatal Diagnosis – A Cytogenetic Approach .Ind J  clinic  biochem  res 2018;5(2) :168-171
  • Pradhan T&Kumari S . Immunomodulators and Immunotherapy in Leprosy .Indian Medical Gazette 2017;1(1) :22-27
  • Kumari S, PandaTK , Pradhan T, Subba S H .Modified Formative Assessment and Its Impact on Undergraduate Medical Learning .Int J Health Sci  Res 2017  ;7(7)  :86-91
  • Kumari S, Dash I,Mangaraj M .Association of serum electrolytes with renal function in Diabetes Mellitus- a pilot study. Int J Clin Bio Res 2016;3(3) :335-339
  • Kumari S, Rakavi R, Mangaraj M. Effect of Guava in Blood Glucose and Lipid Profile in Healthy Human Subjects: A Randomized Controlled Study. J ClinDiagn Res. 2016 Sep;10(9):BC04-BC07. doi: 10.7860/JCDR/2016/21291.8425. Epub 2016 Sep 1. PMID: 27790420; PMCID: PMC5071920.
  • Kumari S, Panda TK, Pradhan T. Lysyl Oxidase: Its Diversity in Health and Diseases. Indian J ClinBiochem. 2017 Jun;32(2):134-141. doi: 10.1007/s12291-016-0576-7. Epub 2016 May 11. PMID: 28428687; PMCID: PMC5382067.
  • KumariS,Panda TK. .Biochemical basis and Emerging molecular targets to treat Diabetic Retinopathy. Int J Clin and Biomed Res   2016; 2(1) :41-49.
  • Dash I ,Kumari S .Biochemical Analysis of End Stage renal disease patients following regular haemodialysis.Int j ClinBiochem Res 2015;2(3):171-175
  • Kumari S, Pradhan T .Thyroid profile in Chronic renal failure .Indian Medical Gazette 2015 ;CXLIX(7) :249-252
  • Kumari S, TyagiS ,Mohapatra E .Lipid profile and oxidative status – a biochemical association in smokers. Biomedicine 2015; 35(1) :060-064
  • Pradhan T ,Kumari S .Evaluation of Oxidative status and zinc level in leprosy patients after zinc supplementation .Int  J  Biol Med Res 2015 ;6(2) :4984-4987.
  • Kumari S ,Pradhan T .Zinc supplementation and its impact on oxidative stress and nutritional status in Leprosy.JClinSci Res 2014; 3(Suppl 3): A105.
  • Kumari S, Pradhan T,  Panda TK  .Trace Minerals and Oxidative Stress in Diabetic Retinopathy .Bangladesh Journal of Medical Science 2014; 13 ( 02) : 175-179.
  • Kumari S& Panda TK. Clinical Perspective of Lipoprotein X . IntJ  Biol Med Res  2013;4 (4): 3694-3697
  • Lakshmi LJ ,Mohapatra E, Zephy DO, Kumari S .Serum Lipids and Oxidative Stress in Hypothyroidism .Journal of Advance Research in Biological Sciences 2013; 5.(1):63-66
  • Pradhan T and Kumari S. Effect of Zinc supplementation on Adenosine Deaminase activity .Indian Medical Gazette. 2013; 376-380
  • Kumari S, Panda TK, Mangaraj M, Mohapatra  P C .Effect of Vitamin-E supplementation on biochemical parameters in diabetic retinopathy patients. Indian Medical Gazette 2011; 45(2) :43-49
  • Kumari S, Panda S, Mangaraj M, Mandal MK, Mahapatra PC. Plasma MDA and antioxidant vitamins in diabetic retinopathy. Indian J ClinBiochem. 2008 Apr;23(2):158-62. doi: 10.1007/s12291-008-0035-1. Epub 2008 Jun 11. PMID: 23105743; PMCID: PMC3453080.
  • Kumari S, Panda S, Mangaraj M, Mandal MK, Mohapatra PC .Plasma MDA and antioxidant vitamins in diabetic retinopathy ;Indian Journal of Clinical Biochemistry 2008;23(2) :158-162
  • Mangaraj M, Kumari S, Nanda R, Pattnaik MR, Mohapatra PC. Pleural fluid MDA and serum-effusion albumin gradient in pleural effusion. Indian J Clin Biochem. 2008 Jan;23(1):81-4. doi: 10.1007/s12291-008-0019-1. Epub 2008 Mar 6. PMID: 23105727; PMCID: PMC3453668.
  • Kumari S ,Tripathy R. Neopterin: Marker of cellular immune response .Odisha Journal of Medical Biochemistry 2005;1(1): 22-25.

Sl No. Title of project Funding agency Project Duration Total Approved

Grant of the Project

(in Rs.)
From to
1. Development of artificial Intelligence-guided predictive model and evaluating its efficacy in comparison to conventional methods to detect ovarian cancer in patients with ovarian mass as Principal Investigator Indian Council of Medical Research

(ICMR)

 2025 2028 1,06,46,230.00
2. Developing a biomarker-based prediction tool using artificial intelligence algorithm for detecting Epithelial Ovarian Cancer among patients presenting with ovarian

mass(Ongoing) as Principal Investigator

 DST,

Odisha

 Mar 2020 June 2023 9,92,000.00
3. Hospital based study toevaluatetheserummiRNA200a,miRNA 200 b and mi RNA 200 c expression as a potential biomarker in Epithelial ovarian cancer patients (ongoing).

As Principal Investigator

 AIIMS,

Intramural grant

 Jan 2021 Jan 2023 4,60,000.00
4 Correlation of Lysyl Oxidase Gene Polymorphism with tumour staging in ovarian cancer and its association with Lysyl oxidase protein-a hospital based Study

As Principal Investigator

 AIIMS,

Intramural grant

 Mar 2017 Mar 2019 1,95,000.00

 

  • There are twenty other Non-funded projects and research works being conducted, few ongoing under supervision as Principal Investigator with interdepartmental collaboration.

Dr. Suchitra Kumari

Orcid ID
Scopus ID

Scopus ID
GS Image

Google Scholar ID
Researchgate ID

Researchgate ID
EXPERTISE INFORMATION
Areas of Interest
    • Extracellular matrix in Cancer Genetics and Machine Learning approach in clinical diagnosis.